Добірка наукової літератури з теми "Anticholesteremic agents"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Anticholesteremic agents".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

За допомогою хмари тегів ви можете побачити ще більше пов’язаних тем досліджень, а відповідні кнопки після кожного розділу сторінки дозволяють переглянути розширені списки книг, статей тощо на обрану тему.

Пов'язані теми наукових робіт:

Статті в журналах з теми "Anticholesteremic agents":

1
Danielson, A. D., E. R. Peo, K. M. Shahani, A. J. Lewis, P. J. Whalen, and M. A. Amer. "Anticholesteremic Property of Lactobacillus Acidophilus Yogurt Fed to Mature Boars2." Journal of Animal Science 67, no. 4 (April 1989): 966–74. http://dx.doi.org/10.2527/jas1989.674966x.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2
Lenhart, Alexander, Wilhelm A. Weihofen, Axel E. W. Pleschke, and Georg E. Schulz. "Crystal Structure of a Squalene Cyclase in Complex with the Potential Anticholesteremic Drug Ro48-8071." Chemistry & Biology 9, no. 5 (May 2002): 639–45. http://dx.doi.org/10.1016/s1074-5521(02)00138-2.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3
Schwab, Fabienne, Wilfred F. van Gunsteren, and Bojan Zagrovic. "Computational Study of the Mechanism and the Relative Free Energies of Binding of Anticholesteremic Inhibitors to Squalene-Hopene Cyclase†." Biochemistry 47, no. 9 (March 2008): 2945–51. http://dx.doi.org/10.1021/bi702067h.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4
Cocimano, V., D. Griffa, G. Marino, R. Cevoli, R. Brigato, and R. Marten Perolino. "Medical and Physical Therapy (Hyperthermia) in Bph." Urologia Journal 59, no. 1 (February 1992): 35–37. http://dx.doi.org/10.1177/039156039205900108.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Medical treatment has a high placebo effect depending on the dynamic and/or obstructive nature of fibroleiomyoadenomatous hypertrophy in which the fibromuscular component may be three times as much as the epithelial one (Clark 1937). It is an indubitable fact that androgynoid transexuals do not develop BPH. This means that hormonal balance is fundamental for BPH control, both direct and through growth factors. The following medicines can be used in growth control: hormones, antihormones, organ extracts, vegetable extracts, anticholesteremics. Hormones are testosterone and its active DHT form, oestrogens, progestogens and their inhibitors, pituitary antiandrogens. The following are not to be discarded: organ and vegetable extracts, anticholesteremic antibiotics, long-term use anticholesteremics. Vasoplegic, ganglioplegic, antireceptory and parasympathomimetic drugs are used as symptomatic ones such as: prostaglandin, bethanechol, prazosin, alphuzosin. A specific temperature rise of the prostate obtained through microwaves (hyperthermia up to 11 °/45°C or up to 70° by thermotherapy) offers a 50% improvement rate. It is confirmed that medical or physical therapy is advisable in the initial stages or in very high risk cases: the placebo effect is remarkable and the ideal drug still has to be found.
5
Uçan, Filiz, and Hatice Aysun Mercimek. "Gıda Endüstrisinde Kitosan Filmlerin Önemi." Turkish Journal of Agriculture - Food Science and Technology 1, no. 2 (December 2013): 79. http://dx.doi.org/10.24925/turjaf.v1i2.79-85.21.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Requirement simple technology, low production costs, lack of polluting effects and reliability in terms of health of it is the most important advantages of edible films. Chitosan that extend the shelf life of food and increase the economic efficiency of packaging materials is one of the new materials used for edible films. Chitosan was obtained by deacetylation of chitin which is the most commonly occurred polymer after cellulose in nature, in shells of arthropods such as crab, shrimp, lobster and in cell walls of some bacteria and fungi. Chitosan has the important bioactive properties such as hemostatic, bacteriostatic, fungistatic, spermicidal, anticarcinogenic, anticholesteremic, antacids, antiulcer, wound and bone healing accelerator and stimulating the immune system. As well as these features, the film forming and barrier properties of its, chitosan is made the ideal material for edible films and coatings in antimicrobial characters. Especially, in the protection of qualities and the improving storage times of fruits and vegetables, have been revealed the potential use of chitosan. The coating food with chitosan films reduces the oxygen partial pressure in the package, maintains temperature with moisture transfer between food and its environment, declines dehydration, delays enzymatic browning in fruits and controls respiration. In addition to, chitosan are also used on issues such as the increasing the natural flavour, setting texture, increasing of the emulsifying effect, stabilization of color and deacidification.
6
Villagra, Alejandro, Natalia Ulloa, Xiaohong Zhang, Zhigang Yuan, Eduardo Sotomayor, and Edward Seto. "Histone Deacetylase 3 Down-regulates Cholesterol Synthesis through Repression of Lanosterol Synthase Gene Expression." Journal of Biological Chemistry 282, no. 49 (October 2007): 35457–70. http://dx.doi.org/10.1074/jbc.m701719200.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
In vertebrates, a key step in the biosynthesis of cholesterol and steroid hormones is the conversion of (S)-2,3-oxidosqualene to lanosterol. The enzyme that catalyzes this complex cyclization/rearrangement step via the protosteryl cation intermediate is lanosterol synthase ((S)-2,3-epoxysqualene mutase (cyclizing, lanosterol forming), EC 5.4.99.7). Because of the crucial role that lanosterol synthase plays in cholesterol biosynthesis, there is great interest in the identification of drugs that target this enzyme for anticholesteremic purposes. Although most studies on lanosterol synthase in the past have focused on the structural and biochemical functions of this enzyme, almost nothing is known concerning how the synthesis of lanosterol synthase is regulated. Here, we report that histone deacetylase 3 (HDAC3) represses transcription from the lanosterol synthase promoter. Overexpression of HDAC3 decreases, whereas knockdown of HDAC3 by small interfering RNA increases, endogenous lanosterol synthase mRNA in cells. Similarly, in transient transfection assays, overexpression of HDAC3 decreases, whereas depletion of HDAC3 increases, expression of a reporter gene under the control of the lanosterol synthase promoter. Stable cell lines that overexpress HDAC3 show a decrease in lanosterol synthase mRNA and have lower cholesterol concentrations compared with parental cells. Extensive promoter analyses coupled with chromatin immunoprecipitation assays reveal that the transcription factor YY1 binds to and recruits HDAC3 to the lanosterol synthase promoter. Together, our results demonstrate that HDAC3 represses the synthesis of a key regulatory enzyme and reveal a novel mechanism by which the cholesterol biosynthetic pathway can be regulated.
7
Sengupta, Raja, and Renée Sieber. "Geospatial Agents, Agents Everywhere . . ." Transactions in GIS 11, no. 4 (July 2007): 483–506. http://dx.doi.org/10.1111/j.1467-9671.2007.01057.x.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8
Simone, Joseph V. "Are We Single Agents, Double Agents, or Free Agents?" Oncology Times 26, no. 8 (April 2004): 3–4. http://dx.doi.org/10.1097/01.cot.0000291847.72455.35.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9
Pollard, Brian J. "New agents or old agents?" Trends in Anaesthesia and Critical Care 1, no. 5-6 (October 2011): 225–26. http://dx.doi.org/10.1016/j.tacc.2011.08.005.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10
Huhns, M. N., and S. Seshardri. "Sensors + agents + networks = aware agents." IEEE Internet Computing 4, no. 3 (2000): 84–86. http://dx.doi.org/10.1109/4236.845396.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "Anticholesteremic agents":

1
Chen, Jingnan. "Hypocholesterolemic activity of microalga schizochytrium sp." Text, HKBU Institutional Repository, 2001. https://repository.hkbu.edu.hk/etd_ra/1417.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2
藍志洪 and Chi-hung Nam. "Effect of cerivastatin on endothelial function in rat aorta." PG_Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2001. http://hub.hku.hk/bib/B42575837.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3
Marinangeli, Christopher P. F. "The composition, biological trafficking and cholesterol-lowering efficacy of sugarcane-derived policosanol supplements /." Electronic Thesis or Dissertation, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=99351.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The cholesterol-lowering efficacy of the original sugarcane-derived Cuban policosanol (OPC) supplement has been attributed to an exclusive policosanol purity and composition. The first objective of the following study was to compare the purity and composition of the OPC and alternative sugarcane derived policosanol (APC) products. Second, to measure blood lipids and policosanol levels in tissues, plasma and feces in hamsters receiving diet fortified with no policosanols, OPC, or an APC (APC1) product. Results indicated that the policosanol purity and composition of the OPC and APC formulations are similar. Lipid levels were not significantly different between groups. Policosanols were undetectable in the plasma and tissues of any animals following policosanol supplementation. Policosanols were excreted at a higher rate in animals consuming APC1. Sugarcane-derived policosanols are not an efficacious cholesterol-lowering therapy. The purity and relative percent composition of the OPC supplement cannot account for its efficacy as a lipid lowering agent.
4
Xiu, Jin. "Distribution and function of nicotinic acetylcholine receptors in glia cells and neurons with focus on the neuroprotective mechanisms of cholesterol-lowering drugs in Alzheimer's disease /." Stockholm, 2006. http://diss.kib.ki.se/2006/91-7140-758-8/.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5
Chapman, Laurie. "In vitro hypocholesterolemic potential of dietary additives used by the Batemi and Maasai people : (Hypocholesterolemic potential of additives from a traditional diet)." Electronic Thesis or Dissertation, McGill University, 1994. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=22725.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Dietary phytochemicals such as saponins have been suggested to have therapeutic uses in the prevention and alleviation of hypercholesterolemia. Thus, twelve Tanzanian plant additives hypothesized to contain saponins and used in soup by the Batemi, were investigated for in vitro hypocholesterolemic potential by: (1) screening for likelihood of detectable saponins using TLC, hemolysis, frothing ability and molluscicidal activity. (2) using changes in hemolytic activity to indirectly examine interactions of plant extracts with cholesterol, cholesterol-analogues, conjugated bile salts and non-conjugated bile salts. (3) using radiolabelled cholesterol to examine direct binding capacity of extracts with cholesterol. Albizia anthelmintica, Myrsine africana and Acacia goetzii were most likely to contain saponins and had significant (p $<$ 0.05) hemolytic activity that was effected by the presence of cholesterol, cholesterol analogues, conjugated and non-conjugated bile salts (p $<$ 0.05). Methanol, ethyl acetate, aqueous and n-butanol extracts of A. anthelmintica and methanol, ethyl acetate and aqueous extracts of A. goetzii bound significant amounts of cholesterol solubilized in ethanol (p $<$ 0.05). Thus, saponins are a detectable component of the Batemi diet and extracts likely containing saponins do interact with chemicals that have been proposed to be involved in in vivo mechanisms of saponin induced hypocholesterolemia. A. anthelmintica and A. goetzii seem likely to have hypocholesterolemic potential as dietary additives.
6
Varady, Kristina A. "Effect of plant sterol supplementation and endurance training on cardiovascular disease risk parameters and cholesterol kinetics in previously sedentary hypercholesterolemic adults." Electronic Thesis or Dissertation, McGill University, 2006. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=111831.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background. A high ratio of total cholesterol to high-density lipoprotein (HDL) cholesterol, in addition to increased levels of small low-density lipoprotein (LDL) particles, are important indicators of cardiovascular disease risk. Therefore, interventions that combine the lowering of total cholesterol and raising of HDL cholesterol concentrations that also increase LDL particle size, may be preventive against cardiovascular disease. Plant sterols decrease total cholesterol and LDL cholesterol levels by 10-15%, while exercise increases HDL cholesterol levels by 4-22%. In view of their complementary effects, combining plant sterols with exercise would appear to be an effective lifestyle therapy to decrease the risk of future cardiovascular disease.
Objective. The aim of this study was to examine the independent and combined effects of plant sterols and exercise on blood lipid levels, and LDL particle size in previously sedentary, hypercholesterolemic adults. An additional objective of this trial was to assess the underlying mechanism by which this combination therapy modulates whole body cholesterol metabolism, to in turn improve lipid profiles.
Methods. In an 8-week, parallel-arm trial, 84 subjects were randomized to 1 of 4 interventions: (1) plant sterols and exercise,(2) plant sterols alone, (3) exercise alone, or (4) control. Blood lipid concentrations were measured using enzymatic kits, and LDL particle size was assessed using polyacrylamide gel electrophoresis. Cholesterol absorption and synthesis were determined using the single isotope single tracer technique and the deuterium incorporation approach, respectively.
Results. Plant sterol supplementation decreased (P < 0.01) total cholesterol concentrations by 8.2% when compared to baseline. Exercise increased (P < 0.01) HDL cholesterol levels by 7.5% while decreasing (P < 0.01) triglyceride concentrations by 13.3% when compared to baseline. Exercise reduced (P < 0.05) post-treatment LDL peak particle size from 255 to 253 A, and decreased (P < 0.05) the proportion of large LDL particles by 13.1%. Plant sterols had no effect on particle size distribution. Plant sterol supplementation decreased (P < 0.01) intestinal cholesterol absorption by 18%, while exercise had no effect on cholesterol absorption. Non-significant increases in cholesterol synthesis rates of 63%, 59%, and 57%, were observed in the combination, exercise, and plant sterol groups, respectively, relative to control.
Conclusion. These findings suggest that this combination therapy yields the most favourable alterations in lipid profiles when compared to each intervention alone. This combined intervention exerts its beneficial effects on lipid profiles by suppressing intestinal cholesterol absorption. Therefore, this lifestyle therapy may be an effective means of decreasing the risk of cardiovascular disease in hypercholesterolemic adults.
7
Tam, Hoi-ling, and 譚凱鈴. "Soluble receptors for advanced glycation end products in type 2 diabetes mellitus." PG_Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2010. http://hub.hku.hk/bib/B43572182.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8
Lau, Vivian Wai Yan 1977. "Effects of plant sterols on plasma lipid profiles, glycemic control of hypercholesterolemic individuals with and without type 2 diabetes." Electronic Thesis or Dissertation, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=80312.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Plant sterols (PS) are effective in reducing plasma lipid concentrations, however, few studies have examined their cholesterol lowering effects in type 2 diabetics. The objective was to assess whether PS consumption alters blood lipid profile in hypercholesterolemic subjects with and without type 2 diabetes. Fifteen control subjects (age = 55.1 +/- 8.5 yr and BMI = 26.9 +/- 3.0kg/m2) and fourteen diabetic subjects (age = 54.5 +/- 6.7 yr and BMI = 30.2 +/- 3.0kg/m2) participated in a double-blinded, randomized, crossover, placebo-controlled feeding trial. The Western diet included either 1.8g/d of PS or cornstarch placebo each provided over 21 d separated by a 28 d washout period. Subjects consumed only foods prepared in Mary Emily Clinical Nutrition Research Unit of McGill University. Total cholesterol (TC) decreased (p < 0.05) from baseline with PS for control and diabetic subjects by 9.7% and 13.6%, respectively. TC decreased (P < 0.05) from baseline with placebo for control and diabetic subjects by 10.9% and 11.6%, respectively. Non high density lipoprotein cholesterol (non-HDL-C) decreased (p < 0.05) from baseline with PS for diabetic subjects by 18.5%. Low density lipoprotein cholesterol (LDL-C) levels were reduced (p < 0.05) from baseline with PS for control and diabetic subjects by 14.9% and 29.8%, respectively. The reduction of LDL-C due to PS alone is greater with type 2 diabetics. There were no significant changes in HDL-C and TG across diets or treatments. It is thus concluded that PS consumption with diet enhances non-HDL-C and LDL-C reduction compared with diet alone in hypercholesterolemic individuals with and without type 2 diabetes. Demonstration for the first time that PS alone are more efficacious in lowering LDL-C and non-HDL-C in diabetic individuals compared to non-diabetics confirm the beneficial effects of PS to help prevent cardiovascular disease (CVD) for this high risk population.
9
Journoud, Mélanie. "The effect of plant sterols on lipid profiles and cholesterol kinetics of hypercholesterolemic individuals with type 2 diabetes compared with non-diabetic controls /." Electronic Thesis or Dissertation, McGill University, 2004. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=80296.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The objective of this study was to compare the effect of phytosterols (PS) on lipid profiles and cholesterol kinetics of hypercholesterolemic individuals with or without type 2 diabetes. It was hypothesised that the response to PS would differ between both groups due to different lipid metabolism. During this randomised, double blind, crossover trial, participants consumed a controlled diet with placebo or PS for 21 days.
Plasma total cholesterol (TC) decreased with placebo and PS (10.9% and 9.7% in non-diabetic versus 11.6% and 13.6% in diabetic participants, p < 0.05). Plasma low-density lipoprotein cholesterol (LDL) significantly decreased with PS in both groups. The reduction in LDL with PS was greater in diabetic compared to non-diabetic individuals (29.8% versus 14.9%, p < 0.05). Cholesterol absorption decreased on average (p = 0.06) by 26.5% with PS compared with placebo in the diabetic group only. Therefore, a controlled heart healthy diet reduced TC and LDL concentrations in non-diabetic and diabetic individuals. Adding PS as adjuncts to a hypocholesterolemic dietary treatment was associated with lower LDL concentrations and cholesterol absorption in hypercholesterolemic participants with type 2 diabetes.
10
Yoshida, Makiko. "Plant sterols and glucomannan as hypocholesterolemic and hypoglycemic agents in subjects with and without type 2 diabetes." Electronic Thesis or Dissertation, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=80900.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
The objective of this research was to examine the effects of plant sterols and glucomannan on lipid profiles, plasma plant sterol levels and glycemic control in mildly hypercholesterolemic subjects. Thirteen type 2 diabetic and sixteen non-diabetic individuals participated in a randomized crossover trial consisting of 4 phases, of 21 days each. During the study period, subjects were supplemented with plant sterols and/or glucomannan. Overall reductions of total cholesterol and low-density lipoprotein (LDL) cholesterol concentrations were greater after consumption of plant sterols and glucomannan compared to plant sterol or glucomannan supplementation alone. Plasma lathosterol levels, indicators of cholesterol biosynthesis, were decreased after combination treatment. The results suggest that a combination of glucomannan and plant sterols substantially improve plasma lipids by reducing cholesterol absorption and synthesis simultaneously. Supplementation of plant sterols and glucomannan can thus be used as an effective treatment for management of circulating cholesterol levels and prevention of cardiovascular disease.

Книги з теми "Anticholesteremic agents":

1
Nesto, Richard W. Cholesterol-lowering drugs: Everything you and your family need to know / Richard W. Nesto and Lisa Christenson. New York: Avon Books, 2000.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2
Mason, Roger. Lower your cholesterol without drugs: Curing high cholesterol naturally. 2nd ed. Garden City Park, NY: Square One Publishers, 2012.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3
Mason, Roger. Lower cholesterol without drugs: A practical guide to using diet and supplements for healthy cholesterol levels. Markham, ON: Safe Goods/New Century Pub., 2001.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4
Steinberg, Daniel. The cholesterol wars: The skeptics vs. the preponderance of evidence. San Diego, Calif: Academic Press, 2007.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5
Steinberg, Daniel. The cholesterol wars: The skeptics vs. the preponderance of evidence. San Diego, Calif: Academic Press, 2007.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6
Steinberg, Daniel. The cholesterol wars: The skeptics vs. the preponderance of evidence. San Diego, Calif: Academic Press, 2007.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7
Gaw, Allan. Statins in General Practice: Pocketbook. London: Taylor & Francis, A Martin Dunitz Book, 2001.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8
International, Symposium on Drugs Affecting Lipid Metabolism (10th 1989 Houston Tex ). Drugs affecting lipid metabolism X: Proceedings of the Xth International Symposium on Drugs Affecting Lipid Metabolism, Texas, November 8-11, 1989. Amsterdam: Excerpta Medica, 1990.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9
Parker, Philip M., and James N. Parker. Zocor: A medical dictionary, bibliography, and annotated research guide to Internet references. San Diego, CA: ICON Health, 2004.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10
Parker, James N., and Philip M. Parker. Cholesterol-lowering drugs: A medical dictionary, bibliography, and annotated research guide to internet references. San Diego, CA: ICON Health Publications, 2004.
Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Anticholesteremic agents":

1
Hempelmann, G., and E. Seidelmayer. "Inotropic Agents/Vasoactive Agents." In Cardiac Anaesthesia: Problems and Innovations, 64–75. Dordrecht: Springer Netherlands, 1986. http://dx.doi.org/10.1007/978-94-009-4265-3_7.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2
Buchanan, W. J. "Agents." In The Complete Handbook of the Internet, 123–45. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-0-306-48331-8_7.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3
O’Brien, Lilian. "Agents." In Philosophy of Action, 136–59. London: Palgrave Macmillan UK, 2015. http://dx.doi.org/10.1057/9781137317483_9.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4
Pérez Castaño, Arnaldo. "Agents." In Practical Artificial Intelligence, 91–135. Berkeley, CA: Apress, 2018. http://dx.doi.org/10.1007/978-1-4842-3357-3_3.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5
Buchanan, W. J. "Agents." In The Handbook of Data Communications and Networks, 127–50. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4020-7870-5_7.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6
Bernard, Georges. "Agents." In Principia Economica, 1–9. Dordrecht: Springer Netherlands, 1989. http://dx.doi.org/10.1007/978-94-009-0935-9_1.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7
Gonzalez-Perez, Cesar. "Agents." In Information Modelling for Archaeology and Anthropology, 245–49. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-72652-6_23.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8
Geldof, Sabine, and Walter Van de Velde. "Competing Software Agents Support Human Agents." In Collaboration between Human and Artificial Societies, 220–33. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/10703260_13.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9
de la Rosa, Josep Lluís, Esteve del Acebo, Beatriz López, and Miquel Montaner. "From Physical Agents to Recommender Agents." In Intelligent Information Agents, 165–78. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/3-540-36561-3_8.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10
Lichtenstein, Lev, and Gerald M. Fraser. "Immunosuppressive agents." In Pocket Guide to Gastrointestinal Drugs, 100–116. Chichester, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118481530.ch7.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Anticholesteremic agents":

1
FASLI, MARIA. "HETEROGENEOUS BDI AGENTS II: CIRCUMSPECT AGENTS." In Proceedings of the 2nd Asia-Pacific Conference on IAT. WORLD SCIENTIFIC, 2001. http://dx.doi.org/10.1142/9789812811042_0010.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2
Williams, Andrew B., and Zijian Ren. "Agents teaching agents to share meaning." In the fifth international conference. New York, New York, USA: ACM Press, 2001. http://dx.doi.org/10.1145/375735.376416.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3
Hasegawa, Tetsuo, Kenta Cho, Fumihiro Kumeno, Shin Nakajima, Akihiko Ohsuga, and Shinichi Honiden. "Interoperability for mobile agents by incarnation agents." In the second international joint conference. New York, New York, USA: ACM Press, 2003. http://dx.doi.org/10.1145/860575.860768.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4
"HTML5 Agents – Mobile Agents for the Web." In 9th International Conference on Web Information Systems and Technologies. SciTePress - Science and and Technology Publications, 2013. http://dx.doi.org/10.5220/0004368800370044.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5
LUAN, XIAOCHENG, YUN PENG, and TIMOTHY FININ. "AGENT CONSUMER REPORTS: OF THE AGENTS, BY THE AGENTS, AND FOR THE AGENTS." In Proceedings of the 2nd Asia-Pacific Conference on IAT. WORLD SCIENTIFIC, 2001. http://dx.doi.org/10.1142/9789812811042_0012.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6
Bickmore, Timothy, and Justine Cassell. "Relational agents." In the SIGCHI conference. New York, New York, USA: ACM Press, 2001. http://dx.doi.org/10.1145/365024.365304.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7
"Industrial agents." In IECON 2013 - 39th Annual Conference of the IEEE Industrial Electronics Society. IEEE, 2013. http://dx.doi.org/10.1109/iecon.2013.6700364.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8
Jones, Michael B. "Interposition agents." In the fourteenth ACM symposium. New York, New York, USA: ACM Press, 1993. http://dx.doi.org/10.1145/168619.168626.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9
Jacques, Richard, Asbjørn Følstad, Elizabeth Gerber, Jonathan Grudin, Ewa Luger, Andrés Monroy-Hernández, and Dakuo Wang. "Conversational Agents." In CHI '19: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2019. http://dx.doi.org/10.1145/3290607.3299034.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10
Kjærup, Maria, Stefania Kouzeli, Mikael B. Skov, Jesper Kjeldskov, Charlotte Schmidt Skov, and Peter Søgaard. "Diagnostic Agents." In CHI '18: CHI Conference on Human Factors in Computing Systems. New York, NY, USA: ACM, 2018. http://dx.doi.org/10.1145/3170427.3188630.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Anticholesteremic agents":

1
Chavez, Deborah J., and Joanne F. Tynon. Forest Service special agents, assistant special agents in charge, senior special agents, and supervisory special agents report: nationwide study. Albany, CA: U.S. Department of Agriculture, Forest Service, Pacific Southwest Research Station, 2007. http://dx.doi.org/10.2737/psw-rp-255.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2
Espinosa, Francisco, and Debraj Ray. Noisy Agents. Cambridge, MA: National Bureau of Economic Research, May 2018. http://dx.doi.org/10.3386/w24627.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3
Wiederhold, Gio, Rudi Studer, Mark Musen, Stefan Decker, and Steffen Staab. Onto-Agents-Enabling Intelligent Agents on the Web. Fort Belvoir, VA: Defense Technical Information Center, May 2005. http://dx.doi.org/10.21236/ada435112.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4
Taylor, C., and C. Wilkerson. Surface polymerization agents. Office of Scientific and Technical Information (OSTI), December 1996. http://dx.doi.org/10.2172/442223.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5
Azoulay, Pierre. Agents of Embeddedness. Cambridge, MA: National Bureau of Economic Research, December 2003. http://dx.doi.org/10.3386/w10142.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6
Harris, J. Milton. Nucleophilic Decontamination Agents. Fort Belvoir, VA: Defense Technical Information Center, June 1989. http://dx.doi.org/10.21236/ada210637.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7
Rus, Daniela. Mobile Information Agents. Fort Belvoir, VA: Defense Technical Information Center, April 2001. http://dx.doi.org/10.21236/ada387701.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8
Wright, Robert, Jeffrey Hudack, Nathaniel Gemelli, Steven Loscalzo, and Tsu Kong Lue. Agents Technology Research. Fort Belvoir, VA: Defense Technical Information Center, February 2010. http://dx.doi.org/10.21236/ada516462.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9
Childress, Terry A., and Penny L. French. Animal Capture Agents. Fort Belvoir, VA: Defense Technical Information Center, January 1990. http://dx.doi.org/10.21236/ada218503.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10
Hirshman, Brian R., Kathleen M. Carley, and Michael J. Kowalchuck. Specifying Agents in Construct. Fort Belvoir, VA: Defense Technical Information Center, July 2007. http://dx.doi.org/10.21236/ada500804.
Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

До бібліографії

Будь ласка, вимкніть ваш блокувальник реклами

Adblock logo Adblock logo Adblock logo

"Grafiati" – це незалежний сервіс, що забезпечує унікальну якість оформлення бібліографічних посилань. Ви можете користуватися нашим сайтом безоплатно, дозволивши показ реклами, або оформити передплату.

Передплатити